L
Lixte Biotechnology Holdings, Inc. (LIXT)
NGM – Real vaqt narxi. Valyuta: USD
7.21
+7.21 (0.00%)
Bozor ochiq: Jul 2, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
7.21
+7.21 (0.00%)
Bozor ochiq: Jul 2, 2026, 4:00 PM EDT
Lixte Biotechnology Holdings, Inc. - bu klinik bosqichdagi biofarmatsevtika va protonli saraton terapiyasi kompaniyasi bo'lib, saraton dorilari ishlab chiqish uchun maqsadlarni aniqlashga, shuningdek, saraton terapiyalarini ishlab chiqish va tijoratlashtirishga qaratilgan. Uning yetakchi mahsulot nomzodi, LB-100, mikrosatellit barqaror metastatik kolorektal saraton kasalligi bo'lgan bemorlar uchun Atezolizumab bilan birgalikda 1b-bosqichli klinik sinovlarda. Kompaniyaning LB-100 preparati doxorubicin bilan birgalikda rivojlangan yumshoq to'qimalar sarkomasi uchun 1b-bosqichda; va LB-100 dostarlimab bilan birgalikda tuxumdonning yorug' hujayrali karsinomasi uchun 1b/2-bosqichda. Kompaniya Niderlandiya Saraton Institutida klinik tadqiqotlar bo'yicha hamkorlik shartnomasiga ega; Ispaniya Sarkoma Guruhi bilan tadqiqotchi tashabbusli klinik sinov uchun hamkorlik shartnomasi; va Niderlandiya Saraton Instituti bilan hamkorlik bo'yicha rivojlanish shartnomasi. Lixte Biotechnology Holdings, Inc. 2005 yilda tashkil etilgan va Boca Raton, Florida shahrida joylashgan.
There is no data to display
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-07-17 | PRE 14A | formpre14a.htm |
| 2026-07-10 | 8-K | form8-k.htm |
| 2026-07-02 | 8-K | form8-k.htm |
| 2026-06-18 | 8-K | form8-k.htm |
| 2026-06-16 | 8-K | form8-k.htm |
| 2026-06-04 | 8-K | form8-k.htm |
| 2026-06-01 | 8-K | form8-k.htm |
| 2026-05-14 | 10-Q | form10-q.htm |
| 2026-04-17 | 8-K | form8-k.htm |
| 2026-03-31 | 10-K | form10-k.htm |